EP 1718634 A1 20061108 - PIPERIDINE DERIVATIVES
Title (en)
PIPERIDINE DERIVATIVES
Title (de)
PIPERIDINDERIVATE
Title (fr)
DERIVES DE PIPERIDINE
Publication
Application
Priority
- EP 2005001446 W 20050214
- DE 102004010132 A 20040227
Abstract (en)
[origin: WO2005082886A1] The invention relates to the compounds of formula (I), wherein R<1>, R<2>, Q, X, Y, m and n are defined as in claim 1. The inventive compounds are potent 5-HT2A antagonists and are suitable for use in the treatment of psychoses, schizophrenia, depression, neurological disorders, memory defects, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease, eating disorders such as bulimia, anorexia nervosa, PMS and/or for positively influencing obsessive-compulsive disorders (OCD).
IPC 8 full level
C07D 401/06 (2006.01); A61K 31/454 (2006.01); A61P 25/00 (2006.01)
CPC (source: EP US)
A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 21/04 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); C07D 401/06 (2013.01 - EP US)
Citation (search report)
See references of WO 2005082886A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
DE 102004010132 A1 20050915; AR 047899 A1 20060301; AU 2005217043 A1 20050909; AU 2005217043 B2 20110623; CA 2557489 A1 20050909; EP 1718634 A1 20061108; JP 2007523930 A 20070823; US 2007197596 A1 20070823; US 7834032 B2 20101116; WO 2005082886 A1 20050909
DOCDB simple family (application)
DE 102004010132 A 20040227; AR P050100705 A 20050225; AU 2005217043 A 20050214; CA 2557489 A 20050214; EP 05715322 A 20050214; EP 2005001446 W 20050214; JP 2007500098 A 20050214; US 59091205 A 20050214